Cargando…
The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial
BACKGROUND: Acupoint sensitization is considered an important factor in the efficacy of acupoint therapy. This study aimed to evaluate the efficacy of acupressure in the prevention of stable angina pectoris using acupoints with different pressure-pain sensitivities. METHODS: A total of 202 patients...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577890/ https://www.ncbi.nlm.nih.gov/pubmed/34765004 http://dx.doi.org/10.1155/2021/7228033 |
_version_ | 1784596155217215488 |
---|---|
author | Huang, Shourui Li, Ling Liu, Jiali Li, Xiujuan Shi, Qingyang Li, Ying Liu, Yanping Li, Mingxiu Ma, Li Ning, Liang Liao, Xiaoyang Ying, Xihui Cai, Weiye Yang, Fuyu Wang, Tengfei Guo, Ru Ma, Weijie Chen, Wenzhu Chen, Jin Sun, Xin |
author_facet | Huang, Shourui Li, Ling Liu, Jiali Li, Xiujuan Shi, Qingyang Li, Ying Liu, Yanping Li, Mingxiu Ma, Li Ning, Liang Liao, Xiaoyang Ying, Xihui Cai, Weiye Yang, Fuyu Wang, Tengfei Guo, Ru Ma, Weijie Chen, Wenzhu Chen, Jin Sun, Xin |
author_sort | Huang, Shourui |
collection | PubMed |
description | BACKGROUND: Acupoint sensitization is considered an important factor in the efficacy of acupoint therapy. This study aimed to evaluate the efficacy of acupressure in the prevention of stable angina pectoris using acupoints with different pressure-pain sensitivities. METHODS: A total of 202 patients were enrolled and randomly assigned to a high-sensitivity group (HSG) (n = 109) in which patients received acupressure at the five acupoints with the highest sensitivity to pain and a low-sensitivity group (LSG) (n = 93) in which patients received acupressure at the five acupoints with the lowest sensitivity to pain. The duration of acupressure treatment was 4 weeks, and the patients were evaluated at baseline, week 4, and week 8. The primary outcome was a change in the frequency of angina attacks from baseline. The secondary outcomes included nitroglycerin consumption, the Canadian Cardiovascular Society classification, and the Seattle Angina Questionnaire score. Adverse events such as bleeding and subcutaneous haemorrhage were recorded in both groups. RESULTS: The effect of acupressure compared with baseline on the prevention of angina pectoris in HSG was better than that in LSG at week 4 (incidence rate ratio (IRR): 0.691 and 95% confidence interval (CI): [0.569, 0.839]) and week 8 (IRR: 0.692 and 95% CI: [0.569, 0.839]). No significant difference between groups was found in the frequency of nitroglycerin consumption at week 4 (odds ratio (OR) = 0.863 and 95% CI: [0.147, 5.077]) or week 8 (OR = 1.426 and 95% CI: [0.211, 9.661]). Two themes in the questionnaire showed significantly different changes from baseline between the two groups. Scores on the angina frequency (AF) subscale had changed more from the baseline in the HSG at week 8 than in the LSG (mean difference (MD) = 3.807 and 95% CI: [0.673, 6.942]). Scores on the treatment satisfaction (TS) subscale had also changed more in the HSG than in the LSG at week 4 (MD = 3.651 and 95% CI: [0.327, 7.327]) and week 8 (MD = 4.220 and 95% CI: [0.347, 7.346]). One patient in the LSG reported bruising at the acupoint. No unexpected safety problems arose. CONCLUSIONS: This study showed that acupressure at acupoints with high sensitivity to pain may effectively reduce the frequency of stable angina pectoris episodes. This trial is registered with NCT03975140. |
format | Online Article Text |
id | pubmed-8577890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-85778902021-11-10 The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial Huang, Shourui Li, Ling Liu, Jiali Li, Xiujuan Shi, Qingyang Li, Ying Liu, Yanping Li, Mingxiu Ma, Li Ning, Liang Liao, Xiaoyang Ying, Xihui Cai, Weiye Yang, Fuyu Wang, Tengfei Guo, Ru Ma, Weijie Chen, Wenzhu Chen, Jin Sun, Xin Evid Based Complement Alternat Med Research Article BACKGROUND: Acupoint sensitization is considered an important factor in the efficacy of acupoint therapy. This study aimed to evaluate the efficacy of acupressure in the prevention of stable angina pectoris using acupoints with different pressure-pain sensitivities. METHODS: A total of 202 patients were enrolled and randomly assigned to a high-sensitivity group (HSG) (n = 109) in which patients received acupressure at the five acupoints with the highest sensitivity to pain and a low-sensitivity group (LSG) (n = 93) in which patients received acupressure at the five acupoints with the lowest sensitivity to pain. The duration of acupressure treatment was 4 weeks, and the patients were evaluated at baseline, week 4, and week 8. The primary outcome was a change in the frequency of angina attacks from baseline. The secondary outcomes included nitroglycerin consumption, the Canadian Cardiovascular Society classification, and the Seattle Angina Questionnaire score. Adverse events such as bleeding and subcutaneous haemorrhage were recorded in both groups. RESULTS: The effect of acupressure compared with baseline on the prevention of angina pectoris in HSG was better than that in LSG at week 4 (incidence rate ratio (IRR): 0.691 and 95% confidence interval (CI): [0.569, 0.839]) and week 8 (IRR: 0.692 and 95% CI: [0.569, 0.839]). No significant difference between groups was found in the frequency of nitroglycerin consumption at week 4 (odds ratio (OR) = 0.863 and 95% CI: [0.147, 5.077]) or week 8 (OR = 1.426 and 95% CI: [0.211, 9.661]). Two themes in the questionnaire showed significantly different changes from baseline between the two groups. Scores on the angina frequency (AF) subscale had changed more from the baseline in the HSG at week 8 than in the LSG (mean difference (MD) = 3.807 and 95% CI: [0.673, 6.942]). Scores on the treatment satisfaction (TS) subscale had also changed more in the HSG than in the LSG at week 4 (MD = 3.651 and 95% CI: [0.327, 7.327]) and week 8 (MD = 4.220 and 95% CI: [0.347, 7.346]). One patient in the LSG reported bruising at the acupoint. No unexpected safety problems arose. CONCLUSIONS: This study showed that acupressure at acupoints with high sensitivity to pain may effectively reduce the frequency of stable angina pectoris episodes. This trial is registered with NCT03975140. Hindawi 2021-11-02 /pmc/articles/PMC8577890/ /pubmed/34765004 http://dx.doi.org/10.1155/2021/7228033 Text en Copyright © 2021 Shourui Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Huang, Shourui Li, Ling Liu, Jiali Li, Xiujuan Shi, Qingyang Li, Ying Liu, Yanping Li, Mingxiu Ma, Li Ning, Liang Liao, Xiaoyang Ying, Xihui Cai, Weiye Yang, Fuyu Wang, Tengfei Guo, Ru Ma, Weijie Chen, Wenzhu Chen, Jin Sun, Xin The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial |
title | The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial |
title_full | The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial |
title_fullStr | The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial |
title_full_unstemmed | The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial |
title_short | The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial |
title_sort | preventive value of acupoint sensitization for patients with stable angina pectoris: a randomized, double-blind, positive-controlled, multicentre trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577890/ https://www.ncbi.nlm.nih.gov/pubmed/34765004 http://dx.doi.org/10.1155/2021/7228033 |
work_keys_str_mv | AT huangshourui thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liling thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liujiali thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT lixiujuan thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT shiqingyang thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liying thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liuyanping thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT limingxiu thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT mali thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT ningliang thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liaoxiaoyang thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT yingxihui thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT caiweiye thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT yangfuyu thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT wangtengfei thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT guoru thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT maweijie thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT chenwenzhu thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT chenjin thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT sunxin thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT huangshourui preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liling preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liujiali preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT lixiujuan preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT shiqingyang preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liying preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liuyanping preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT limingxiu preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT mali preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT ningliang preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT liaoxiaoyang preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT yingxihui preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT caiweiye preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT yangfuyu preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT wangtengfei preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT guoru preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT maweijie preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT chenwenzhu preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT chenjin preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial AT sunxin preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial |